Cargando…
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434637/ https://www.ncbi.nlm.nih.gov/pubmed/32822684 http://dx.doi.org/10.1016/j.jinf.2020.08.021 |
_version_ | 1783572190633918464 |
---|---|
author | Nakajima, Kento Abe, Takeru Saji, Ryo Ogawa, Fumihiro Taniguchi, Hayato Yamaguchi, Keishi Sakai, Kazuya Nakagawa, Tomoki Matsumura, Reo Oi, Yasufumi Nishii, Mototsugu Takeuchi, Ichiro |
author_facet | Nakajima, Kento Abe, Takeru Saji, Ryo Ogawa, Fumihiro Taniguchi, Hayato Yamaguchi, Keishi Sakai, Kazuya Nakagawa, Tomoki Matsumura, Reo Oi, Yasufumi Nishii, Mototsugu Takeuchi, Ichiro |
author_sort | Nakajima, Kento |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7434637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74346372020-08-19 Serum cholinesterase associated with COVID-19 pneumonia severity and mortality Nakajima, Kento Abe, Takeru Saji, Ryo Ogawa, Fumihiro Taniguchi, Hayato Yamaguchi, Keishi Sakai, Kazuya Nakagawa, Tomoki Matsumura, Reo Oi, Yasufumi Nishii, Mototsugu Takeuchi, Ichiro J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-02 2020-08-19 /pmc/articles/PMC7434637/ /pubmed/32822684 http://dx.doi.org/10.1016/j.jinf.2020.08.021 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Nakajima, Kento Abe, Takeru Saji, Ryo Ogawa, Fumihiro Taniguchi, Hayato Yamaguchi, Keishi Sakai, Kazuya Nakagawa, Tomoki Matsumura, Reo Oi, Yasufumi Nishii, Mototsugu Takeuchi, Ichiro Serum cholinesterase associated with COVID-19 pneumonia severity and mortality |
title | Serum cholinesterase associated with COVID-19 pneumonia severity and mortality |
title_full | Serum cholinesterase associated with COVID-19 pneumonia severity and mortality |
title_fullStr | Serum cholinesterase associated with COVID-19 pneumonia severity and mortality |
title_full_unstemmed | Serum cholinesterase associated with COVID-19 pneumonia severity and mortality |
title_short | Serum cholinesterase associated with COVID-19 pneumonia severity and mortality |
title_sort | serum cholinesterase associated with covid-19 pneumonia severity and mortality |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434637/ https://www.ncbi.nlm.nih.gov/pubmed/32822684 http://dx.doi.org/10.1016/j.jinf.2020.08.021 |
work_keys_str_mv | AT nakajimakento serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT abetakeru serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT sajiryo serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT ogawafumihiro serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT taniguchihayato serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT yamaguchikeishi serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT sakaikazuya serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT nakagawatomoki serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT matsumurareo serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT oiyasufumi serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT nishiimototsugu serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality AT takeuchiichiro serumcholinesteraseassociatedwithcovid19pneumoniaseverityandmortality |